[1] Vergadi E, Chang MS, Lee C, et al. Early macrophage re-cruitment and alternative activation are critical for the later development of hypoxia-induced pulmonary hypertension[J]. Circulation, 2011, 123(18):1986-1995. [2] Bartelds B, van Loon RL, Mohaupt S, et al. Mast cell inhi-bition improves pulmonary vascular remodeling in pulmonary hypertension[J]. Chest, 2012, 141(3):651-660. [3] Snow JB, Kitzis V, Norton CE, et al. Differential effects of chronic hypoxia and intermittent hypoxia and eucapnic hypox-ia on pulmonary vasoreactivity[J]. J Appl Physiol (1985), 104(1):110-118. [4] Ludwig MG, Vanek M, Guerini D, et al. Proton-sensing G-protein-coupled receptors[J]. Nature, 2003, 425(6953):93-98. [5] Murakami N, Yokomizo T, Okuno T, et al. G2A is a pro-ton-sensing-protein-coupled receptor antagonized by lysophos-phatidylcholine[J]. J Biol Chem, 2004, 279(41):42484-42491. [6] 中华医学会呼吸病学分会, 慢性阻塞性肺疾病学组. 慢性阻塞性肺疾病诊治指南(2013年修订版)[J]. 中华结核和呼吸杂志, 2013, 36(4):255-264. [7] 葛均波, 徐永健. 内科学第8版[M]. 北京:人民卫生出版社, 2013:138. [8] 田红军, 杨敬平, 王秀香. 骨髓间充质干细胞移植对大鼠低氧性肺动脉高压的影响[J]. 中国应用生理学杂志, 2014, 29(3):233-236. [9] Bauer EM, Shapiro R, Zheng H, et al. High mobility group box-1 contributes to the pathogenesis of experimental pul-monary hypertension via activation of toll-like receptor 4[J]. Mol Med, 2013, 18:1509-1518. [10] Halestrap AP. Monocarboxylic acid transport[J]. Compr Physiol, 2013, 3(4):611-643. [11] Vijay N, Morris ME. Role of monocarboxylate transporters in drug delivery to the brain[J]. Curr Pharm, 2014, 20(10):1487-1498. [12] Orr AW, Hastings NE, Blackman BR, et al. Complex regu-lation and function of the inflammatory smooth muscle cell phenotype in atherosclerosis[J]. Vasc Res, 2010, 47(2):168-180. |